Twenty-eight life science companies, evenly divided between early-stage and later-stage companies, have been selected to make presentations at the Southeast BIO venture capital conference in Atlanta.

The conference, titled “Where Innovation Meets Opportunity,” is set for Nov. 8-10 at the InterContinental Buckhead Hotel.

The early-stage companies include:

  • 3Ti (Atlanta)
  • Abeome Corporation (Athens, Ga.)
  • Addrenex Pharmaceuticals, Inc. (Morrisville, N.C.)
  • AerovectRx Corporation (Atlanta, Ga.)
  • AudioFusion Inc. (Winston Salem, N.C.)
  • BioDtech, Inc. (Nashville, Tenn.)
  • Celtaxsys, Inc. (Atlanta)
  • InterveXion Therapeutics, LLC (Little Rock, Ark.)
  • IntraTherm LLC (Little Rock, Ark.)
  • NanoVici, Inc. (Atlanta)
  • OcuCure Therapeutics (Roanoke, Vir.)
  • Precision BioSciences, Inc. (Durham, N.C.)
  • Precision Human BioLaboratories, Inc. (Cary, N.C.)
  • ViewRay, Inc. (Gainesville, Fla.)
  • The 14 later-stage companies include:

  • Adlyfe Inc (Rockville, Md.)
  • AGTC (Alachua, Fla.)
  • Aldagen, Inc (Durham, N.C.)
  • Altor Bioscience Corporation (Miramar, Fla.)
  • Argos Therapeutics, Inc. (Durham, N.C.)
  • Biolex Therapeutics (Pittsboro, N.C.)
  • DiaKine Therapeutics, Inc. (Charlottesville, Vir.)
  • Nanotherapeutics, Inc. (Alachua, Fla.)
  • NeoVista, Inc. (Atlanta)
  • NephroGenex (Cary, N.C.)
  • Phase Bioscience, Inc. (Durham, N.C.)
  • Regado Biosciences (Durham, N.C.)
  • RFS Pharma, LLC (Tucker, Ga.)
  • Serenex, Inc. (Durham, N.C.)
  • The SE BIO conference has been put on annually since 1999.

    SE BIO: www.sebio.org